Sinovac vaccine 78pct effective in Brazil trial, experts call for more details



A coronavirus vaccine developed by China's Sinovac Biotech was 78 percent effective in a late-stage Brazilian trial with no severe Covid-19 cases, researchers said on Thursday, although a lack of data details stirred calls for more transparency.

The trial results, closely watched by developing countries counting on the vaccine to begin mass inoculations to help end a raging pandemic, was below preliminary findings from Turkish researchers and lacked detailed data provided on US and European vaccines...

All Access Plan
starting from


per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In